MetaCap

Celldex Therapeutics Statistics

NASDAQ: CLDXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

27.42-0.54 (-1.93%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Celldex Therapeutics by the numbers

Celldex Therapeutics has a market capitalization of $2.15 billion based on 78.55M shares outstanding. With trailing EPS of $-4.29, Celldex Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.3% below its 50-day average and 16.7% below its 200-day average.

Average daily trading volume is 1.33M shares, or about $36.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CLDX valuation vs. peer median

CLDX compared with the median of 8 peer companies
MetricCLDXPeer medianDifference
Market cap$2.15B$547.30M+294%
Avg. volume1.33M1.71M-22%

Peer median across 8 companies: NEOG, NTLA, QUIT, QDEL, MYGN, TKNO, NNNN, ICCC.

Valuation

Price / sales (latest FY)
1,393.98
EPS (TTM)
$-4.29

Price and trading

Previous close
27.96
Open
27.05
Day range
26.64 – 28.43
52-week range
22.33 – 45.14
52-week change
+5.79%
Beta
—
Volume
1.72M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.15B
Forward Pe
-6.57
Eps
-4.29
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
45.14
Week52 Low
22.33
Avg Volume
1.33M
Shares Outstanding
78.55M
Ma50
30.92
Ma200
32.93
Earnings Date
Nov 5, 2026
Pct From52w High
-39.26%
Pct From52w Low
22.79%

Related